Company record
Cygnus Technologies, Inc develops and manufactures pharmaceutical solutions, focusing on the biotechnology and biopharmaceutical sectors. Its portfolio includes enzyme‑linked immunosorbent assay (ELISA) kits, a range of reagents and antigens, as well as specialized components such as enzyme‑conjugate stabilizer, tetramethyl benzidine (TMB), the BCIP/NBT substrate pair, and para‑Nitrophenylphosphate (PNPP). In addition to product offerings, Cygnus provides technical services that encompass antibody qualification, sample testing, and assay qualification to support customer development programs.
This directory record does not yet have a linked material-flow brief.